BamSEC and AlphaSense Join Forces
Learn More

Reata Pharmaceuticals Inc

Formerly NASDAQ: RETA
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.7
from 10-Q 6 pages Termination of Expansion Agreement
12/34/56
EX-10.6
from 10-Q 23 pages Employment Agreement by and Between Reata Pharmaceuticals, Inc. and Rajiv Patni
12/34/56
EX-10.5
from 10-Q 23 pages Reata Pharmaceuticals, Inc. Indemnification Agreement
12/34/56
EX-10.4
from 10-Q 16 pages Second Amendment to Lease Agreement
12/34/56
EX-10
from 10-Q 34 pages Amended and Restated Development and Commercialization Funding Agreement Article 1 Definitions
12/34/56
EX-10
from 10-Q 4 pages Amendment No. 2 to Exclusive License Agreement
12/34/56
EX-10
from 10-K 8 pages Reata Pharmaceuticals, Inc. Eighth Amended and Restated Non-Employee Director Compensation Policy
12/34/56
EX-10
from 10-K 7 pages Reata Pharmaceuticals, Inc. Seventh Amended and Restated Non-Employee Director Compensation Policy
12/34/56
EX-10.3
from 10-Q 23 pages Reata Pharmaceuticals, Inc. Indemnification Agreement
12/34/56
EX-10.2
from 10-Q 4 pages Seventh Supplement to Exclusive License and Supply Agreement Regarding Phase 3 Clinical Study in Japan
12/34/56
EX-10.1
from 8-K 23 pages Reata Pharmaceuticals, Inc. Indemnification Agreement
12/34/56
EX-10.2
from 10-Q 4 pages Seventh Supplement to Exclusive License and Supply Agreement Regarding Phase 3 Clinical Study in Japan
12/34/56
EX-10.1
from 10-Q 3 pages Amendment No. 1 to Exclusive License Agreement
12/34/56
EX-10.50
from 10-K 8 pages Sixth Amended and Restated Non-Employee Director Compensation Policy 1
12/34/56
EX-10.49
from 10-K 3 pages Notice of Grant of Restricted Stock Units
12/34/56
EX-10.48
from 10-K 3 pages Notice of Grant of Restricted Stock Units
12/34/56
EX-10.38
from 10-K 5 pages Lease Amendment No. 13
12/34/56
EX-10.31
from 10-K 4 pages Fourth Supplement to Exclusive License and Supply Agreement Regarding Milestone Payments, Supply Price and Products Manufacturing
12/34/56
EX-10.30
from 10-K 4 pages Third Supplement to Exclusive License and Supply Agreement Regarding Phase 3 Clinical Study (Alport Syndrome) in Japan
12/34/56
EX-10.29
from 10-K 190 pages Collaboration Agreement Between Reata Pharmaceuticals, Inc. and Abbott Pharmaceuticals Pr Ltd. Dated as of December 9, 2011
12/34/56